Abbott Laboratories stock holds near weekly high, eyes resistance after modest climb

Traders Union
All News
Companies
Abbott Laboratories rises 0.90% today

Highlights

ABT is in a short- and medium-term uptrend but faces significant long-term resistance near its 200-day moving average.
Momentum and oscillators are strongly overbought, reflecting aggressive buying and potential for increased volatility near key resistance.
ABT is expected to consolidate between $100 and $104 next week, with a higher probability of a pullback than a breakout.

Uptrend momentum as price holds above short-term supports but meets long-term resistance

ABT is trading at $101.58, sitting well above the MA-20 ($93.01) and MA-50 ($89.65), but still below the MA-200 ($109.83), signaling a constructive short- and medium-term uptrend with lingering long-term resistance. The Ichimoku Kijun on D1 is at $94.54, classifying this level as immediate support for the current price. For near-term support, look to the Kijun ($94.54) and MA-100 ($96.33), while MA-200 ($109.83) and the cluster around MA-200 remain key resistance.

Overbought signals emerge as intraday action tests upper weekly range

Momentum signals on D1 are strong, with the MACD indicating a buy and ADX at 18.77, suggesting a trend present but not yet strongly established. Oscillators highlight pronounced overbought conditions, as Stoch RSI sits at 100 and CCI reads 200, while RSI itself is elevated at 66.68. BBP, at 7.81 and classified as overbought, confirms aggressive buyer dominance in intraday action. The AO trend supports this momentum. ABT is trading at $101.58, up from $100.67 a week ago, reflecting a 0.90% gain. The price stands at the very top of this week’s range, with weekly volatility at 16.33%. This suggests a recovery from the weekly low and a test of upper-range resistance.

Pullback risk elevated as upside odds weaken amid key resistance

For the next week, the expected range is $100.12 to $104.20, keeping ABT near the upper segment of its 52-week band ($81.97—$137.49). The probability of a price increase is very low (less than 20%), given sell signals on W1 MACD, MA-50, and ADX, despite a neutral-to-positive RSI. The probability of a pullback is much higher. Baseline scenario: ABT holds between $100 and $104, consolidating near resistance. If buyers break above $104.20, a short-term bullish extension could develop. Should selling pressure prevail, a slip below $100.12 could trigger a pullback toward the $97 zone, still well above the 52-week low.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Earlier, analysts noted that Abbott Laboratories demonstrated near-term strength following upbeat earnings while still facing longer-term technical resistance. As the current situation unfolds, investors should monitor whether the stock can establish sustained momentum above recent highs, as this would be a key signal for the next directional move.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.